None listed
Conditions
Interventions
Others : •We will divide the subjects enrolled by the inclusion and exclusion criteria into three groups.
•We will randomize subjects in the same proportions to Intervention Group 1 (Basic Healthcare
Sponsors
Hotel Shilla
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Age: over 20 years old 2) body mass index (BMI) = 25 kg / m2 3) Metabolic Syndrome * Those who meet 3 or more of the following 5 elements (1) abdominal obesity: waist = 90 cm (male), 85 cm (female) (2) blood pressure = 130/85 mmHg (3) fasting blood sugar = 100 mg / dL (4) triglyceride = 150 mg / dL or Patients taking fibrate medications (5) high-density lipoprotein cholesterol (HDL-C) <40 mg /dL (male), 50 mg /dL (Female) 4) Patients who can understand, read, and write the purpose of clinical research 5) Patients who can use the smartphone application used for clinical research 6) Patients who voluntarily participate and sign a consent form
Exclusion criteria
Exclusion criteria: 1) Participants in a diet or weight loss healthcare program within 12 weeks prior to the screening visit 2) Patients who are currently in hospital or are expected to need hospitalization within the clinical study period 3) Patients diagnosed with myocardial infarction or stroke within the last year 4) Patients with end stage renal failure who need renal replacement therapy Serum creatine levels are more than 1.5 times the upper limit of normal 5) Pregnant women 6) Liver Failure (Severe Liver Disorder Patients) Serum liver enzyme (AST or ALT) is more than five times the upper limit of normal 7) Uncontrolled chronic lung disease 8) Phentermin, orlistat ? ????? ?? ???? ??? ?? 9) Patients taking drugs that may affect their weight (eg psychiatric drugs) 10) Patients who have a medical condition that is likely to affect clinical research results, such as clinically significant neurological disease, gastrointestinal disease, or malignant tumor, or are inappropriate for participation in clinical research, as judged by the investigator. 11) Participants in other clinical studies (excluding observational studies) within 12 weeks before the screening visit 12) Type I and Type II Diabetics requiring Insulin Treatment 13) Participants who have had a weight change of more than 10% of their weight in the last year
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in body weight, body mass index, and metabolic syndrome prevalence | — |
Secondary
| Measure | Time frame |
|---|---|
| Test results and lifestyle changes related to obesity and metabolic syndrome, including blood pressure, serum lipids, liver function, uric acid, blood sugar, and insulin resistance | — |
Countries
Korea, Republic of
Contacts
Public ContactJihyun Nam
Kangbuk Samsung Medical Center
Outcome results
None listed